GeneReach Biotechnology Market Cap

GeneReach Biotechnology has a market cap or net worth of 1.09 billion as of March 9, 2026. Its market cap has decreased by -30.09% in one year.

Market Cap

1.09B

Enterprise Value

1.06B

Revenue

215.32M

Ranking

n/a

PE Ratio

n/a

Stock Price

18.75

Market Cap Chart

Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 1.09B, a decrease of -14.30%. That is a compound annual growth rate of -1.15%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	1.09B	0.53%
Dec 31, 2025	1.08B	-34.10%
Dec 31, 2024	1.65B	-27.38%
Dec 29, 2023	2.27B	-25.28%
Dec 30, 2022	3.03B	-20.04%
Dec 30, 2021	3.79B	-27.82%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lukas Biomedical	1.12B
Holy Stone Healthcare	1.10B
Level Biotechnology	1.10B
Enimmune	1.27B
Great Novel Therapeutics Biotech & Medicals	1.42B
Taiwan Advance Bio-Pharmaceutical	958.50M
TCI GENE	949.86M
Meribank Biotech	1.45B

Market Cap Rankings